Comparative Study of Clinical Characteristics according to Therapeutic Efficacy and Drug Survival of Cyclosporine or Methotrexate in Psoriasis Vulgaris

참고문헌 (7)

1. Strober BE, "Methotrexate and cyclosporine in psoriasis revisited", Semin Cutan Med Surg, 33(2 Suppl 2), pp.S27~S30 (2014)
2. Kanelleas A, "The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept", Clin Exp Dermatol, 36, pp.845~850 (2011)
3. Zweegers J, "Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice : results from the prospective, multicenter BioCAPTURE cohort", Br J Dermatol, 176, pp.786~793 (2017)
4. ), "J Am Acad Dermatol", 2016, 851~861
5. Menting SP, "Drug survival is not significantly different between biologics in patients with psoriasis vulgaris : a single-centre database analysis", Br J Dermatol, 171, pp.875~883 (2014)
6. van Lümig PP, "Adalimumab therapy for psoriasis in real-world practice: efficacy, safety and results in biologicnaïve vs. non-naïve patients", J Eur Acad Dermatol Venereol, 27, pp.593~600 (2013)
7. Shear NH, "Longterm efficacy and safety of infliximab maintenance therapy in patients with plaque-type psoriasis in real-world practice", Br J Dermatol, 171, pp.631~641 (2014)

관련 논문AI추천